Yifeng Pharmacy (603939) - Total Liabilities

Latest as of September 2025: CN¥14.41 Billion CNY ≈ $2.11 Billion USD

Based on the latest financial reports, Yifeng Pharmacy (603939) has total liabilities worth CN¥14.41 Billion CNY (≈ $2.11 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Yifeng Pharmacy - Total Liabilities Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's total liabilities have evolved over time, based on quarterly financial data. See Yifeng Pharmacy short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Yifeng Pharmacy Competitors by Total Liabilities

The table below lists competitors of Yifeng Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
Hengan International Group Company Limited F:HGNC	Germany	€20.54 Billion
Wockhardt Limited NSE:WOCKPHARMA	India	Rs-46.57 Billion
Hanmi Pharm Co Ltd KO:128940	Korea	₩694.79 Billion
SolarEdge Technologies Inc NASDAQ:SEDG	USA	$1.85 Billion
Shenyang Jinshan Energy Co Ltd SHG:600396	China	CN¥9.63 Billion
GEK TERNA Holdings Real Estate Construction S.A AT:GEKTERNA	Greece	€6.42 Billion
HARBOUR ENE.SP.ADR LS-50 F:PQQ2	Germany	€22.89 Billion
Shenzhen Hopewind Elec Co Ltd SHG:603063	China	CN¥4.03 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Yifeng Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Yifeng Pharmacy.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yifeng Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yifeng Pharmacy (2011–2024)

The table below shows the annual total liabilities of Yifeng Pharmacy from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥16.58 Billion ≈ $2.43 Billion	+21.12%
2023-12-31	CN¥13.69 Billion ≈ $2.00 Billion	+14.87%
2022-12-31	CN¥11.92 Billion ≈ $1.74 Billion	+29.71%
2021-12-31	CN¥9.19 Billion ≈ $1.34 Billion	+28.18%
2020-12-31	CN¥7.17 Billion ≈ $1.05 Billion	+60.49%
2019-12-31	CN¥4.47 Billion ≈ $653.56 Million	+20.77%
2018-12-31	CN¥3.70 Billion ≈ $541.18 Million	+130.72%
2017-12-31	CN¥1.60 Billion ≈ $234.56 Million	+28.65%
2016-12-31	CN¥1.25 Billion ≈ $182.31 Million	+22.47%
2015-12-31	CN¥1.02 Billion ≈ $148.86 Million	+55.27%
2014-12-31	CN¥655.19 Million ≈ $95.87 Million	+24.99%
2013-12-31	CN¥524.21 Million ≈ $76.71 Million	+24.92%
2012-12-31	CN¥419.63 Million ≈ $61.40 Million	-13.86%
2011-12-31	CN¥487.12 Million ≈ $71.28 Million	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$3.53 Billion

CN¥24.13 Billion CNY

Market Cap Rank

#4538 Global

#782 in China

Share Price

CN¥19.90

Change (1 day)

+0.61%

52-Week Range

CN¥19.70 - CN¥26.22

All Time High

CN¥967.78